Stock Price Quote

MAX HEALTHCARE INSTITUTE LTD.

NSE : MAXHEALTHBSE : 543220ISIN CODE : INE027H01010Industry : Hospital & Healthcare ServicesHouse : Max
BSE771.95-4.15 (-0.53 %)
PREV CLOSE ( ) 776.10
OPEN PRICE ( ) 779.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 28072
TODAY'S LOW / HIGH ( )748.45 779.90
52 WK LOW / HIGH ( )435.1 909
NSE772.85-5.25 (-0.67 %)
PREV CLOSE( ) 778.10
OPEN PRICE ( ) 779.00
BID PRICE (QTY) 772.85 (503)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1911786
TODAY'S LOW / HIGH( ) 748.45 779.55
52 WK LOW / HIGH ( )435.05 910
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year :
Management Info
Abhay Soi - Chairman Abhay Soi - Managing Director
Registered Office

Address 401, 4th Floor, Man Excellenza,S. V. Road,Vile Parle (West),
Mumbai,
Maharashtra-400056

Phone 022-26101035

Email secretarial@maxhealthcare.com / investors@maxhealthcare.com

Website www.maxhealthcare.in

Registrars Details
Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE

NEWS

03Apr Update On Acquisition Of Land Parcel
Update on acquisition of Land Parcel allotted through e-auction for sett..
19Mar Re-Appointment Of Independent Directors
The Board has approved re-appointment of Mr. Mahendra Gumanmalji Lodha a..
18Mar Grant Of Options Under Max Healthcare
Grant of 2,80,670 options under Max Healthcare Institute Limited - Emplo..
18Mar Max Healthcare Institute informs about
Max Healthcare Institute has informed that Nomination & Remuneration..
26Feb JSW Infrastructure, PFC and NTPC to se
JSW Infrastructure has received Letter of Award (LoA) from V.O. Chidamba..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit1581.26943.1
Gross Profit 2033.3 5631.4
Operating Profit 2428.37282.6
Net Sales 5907.519046.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)
peergroup  6170.05 (1.68%)
M.Cap ( in Cr)88715.85
Global Health (BSE)
peergroup  1402.45 (2.25%)
M.Cap ( in Cr)37656.82
Dr Agarwals Eye Hsp (BSE)
peergroup  3282.00 (0.94%)
M.Cap ( in Cr)1542.54
Thyrocare Tech. (BSE)
peergroup  634.85 (2.99%)
M.Cap ( in Cr)3361.70
Yatharth Hospital (BSE)
peergroup  460.10 (2.39%)
M.Cap ( in Cr)3949.97

Shareholding Pattern

NON-INSTITUTION 3.96%
PROMOTERS 23.75%
FI/BANKS/INSURANCE 2.23%
MUTUAL FUNDS/UTI 12.33%
FII 0.01%
GOVERNMENT 0%

About Max Healthcare Institute Ltd.

Max Healthcare Institute Ltd. was incorporated in the year . Its today's share price is 771.95. Its current market capitalisation stands at Rs 75026.78 Cr. In the latest quarter, company has reported Gross Sales of Rs. 19046.6 Cr and Total Income of Rs.20497.6 Cr. The company's management includes Varadhan Moorthy, Narayan K Seshadri, Anil Bhatnagar, Amrita Gangotra, Pranav Amin, Michael Thomas Neeb, Mahendra Gumanmalji Lodha, K Narasimha Murthy, Abhay Soi, Abhay Soi, Dhiraj Aroraa.

It is listed on the BSE with a BSE Code of 543220 , NSE with an NSE Symbol of MAXHEALTH and ISIN of INE027H01010. It's Registered office is at 401, 4th Floor, Man Excellenza,S. V. Road,Vile Parle (West)Mumbai-400056, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells, Price Waterhouse, SR Batliboi & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.